Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

Am J Hematol. 2022 Apr;97(4):E129-E132. doi: 10.1002/ajh.26454. Epub 2022 Jan 19.

Authors

Graça M Dores¹, Afrouz Nayernama¹, Connie Cheng¹, Charlotte Moureaud¹, S Christopher Jones¹

Affiliation

¹ Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

PMID: 34985778
DOI: 10.1002/ajh.26454

No abstract available

Publication types

Letter

MeSH terms

Adverse Drug Reaction Reporting Systems
Anemia, Hemolytic* / chemically induced
Carbazoles*
Humans
Piperidines / adverse effects
United States / epidemiology
United States Food and Drug Administration

Substances

Carbazoles
Piperidines
alectinib